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Summary  
Background 
The scale-up of tobacco control, especially following the adoption of the Framework Convention for 
Tobacco Control, is a major public health success story. Nonetheless, smoking remains a leading risk for 
early death and disability globally, and therefore continues to require sustained political commitment. 
The Global Burden of Diseases, Injuries, and Risk Factors study (GBD) offers a robust platform through 
which global, regional, and national progress toward achieving smoking-related targets can be assessed. 
 
Methods 
We synthesised 2,818 data sources with spatiotemporal Gaussian process regression and produced 
estimates of daily smoking prevalence by sex, age group, and year for 195 countries and territories from 
1990 to 2015. We analysed 38 risk-outcome pairs to generate estimates of smoking-attributable 
mortality and disease burden, as measured by disability-adjusted life years (DALYs). We then performed 
a cohort analysis of smoking prevalence by birth-year cohort to better understand temporal age 
patterns in smoking. Last, we conducted a decomposition analysis, wherein we parsed out changes in 
all-cause smoking-attributable DALYs due to changes in population growth, population ageing, smoking 
prevalence, and risk-deleted DALY rates. Finally, we explored results by level of development using the 
Socio-demographic Index (SDI). 
 
Results 
Globally, the age-standardised prevalence of daily smoking was 25.0% (95% uncertainty interval 24.2–
25.7%) for men and 5.4% (5.1–5.7%) for women, representing 28.4% (25.8-31.1%) and 34.4% (29.4–
38.6%) reductions, respectively, since 1990. A greater percentage of countries and territories achieved 
significant annualised rates of decline in smoking prevalence from 1990 to 2005 than from 2005 to 2015; 
however, only two countries saw significant annualised increases in smoking prevalence between 2005 
to 2015 (Congo for men and Kuwait for women). In 2015, 11.5% of global deaths (6.4 million, [5.7–7.0 
million]) were attributable to smoking worldwide, of which 52.2% took place in four countries (China, 
India, USA, and Russia). Smoking was ranked among the five leading risk factors by DALYs in 109 
countries and territories in 2015, rising from 88 geographies in 1990. In terms of birth cohorts, male 
smoking prevalence followed similar age patterns across levels of SDI, whereas much more 
heterogeneity was found in age patterns for female smokers by level of development. While smoking 
prevalence and risk-deleted DALY rates mostly decreased by sex and SDI quintile, population growth, 
population aging – or a combination of both – drove rises in overall smoking-attributable DALYs among 
low to middle SDI geographies between 2005 and 2015. 
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Interpretation 
The pace of progress in reducing smoking prevalence has been heterogeneous across geographies, 
development status, and sex – and as highlighted by more recent trends, maintaining past rates of 
decline should not be taken for granted, particularly among women and in low to middle SDI countries. 
Beyond the influence of the tobacco industry and societal mores, a critical challenge facing tobacco 
control initiatives is that demographic forces are poised to heighten smoking’s global toll, unless 
progress in preventing initiation and promoting cessation can be substantially accelerated. Greater 
success in tobacco control is possible but requires effective, comprehensive, and adequately 
implemented and enforced policies, which may in turn require global and national levels of political 
commitment beyond what has been achieved during the past 25 years. 
 
Funding 
Bill & Melinda Gates Foundation and Bloomberg Philanthropies. 
 
Research in Context  
Evidence before this study 
Smoking is a widely-recognised risk factor for premature morbidity and mortality, but adequate 
monitoring of smoking levels and trends throughout the world has been challenging. Increasing 
investments in multi-country survey series has improved the availability of data on smoking behaviours, 
particularly among lower income countries, but such surveys are relatively infrequent and differences in 
survey questions and definitions can hinder appropriate comparisons between countries and across 
time. Through the Global Burden of Diseases, Injuries, and Risk Factors study in 2013 (GBD 2013), 
researchers collated a wide array of data sources and sythesised them to produce comprehensive, 
comparable estimates of daily smoking prevalence, by sex and age group, for 188 countries from 1990 
to 2013. Additional analyses, including those by Bilano and colleagues in 2015, have applied similar 
methods to project trends in tobacco use through 2025 in 173 countries for men and 178 countries for 
women. 
 
Added value of this study 
With the 2015 update to the GBD, the number of data sources included was substantially increased and 
the estimation process for both smoking prevalence and attributable disease burden, as measured by 
disability-adjusted life-years (DALYs), has been improved. Two novel analyses are also provided through 
the GBD 2015 study: a birth cohort analysis of smoking patterns over time and a decomposition analysis 
to parse out changes in total DALYs attributable to smoking to changes in population growth, population 
ageing, smoking prevalence, and risk-deleted DALY rates. The latter assessment can assist with 
identifying which factors are contributing to changes in disease burden due to smoking – demographic 
trends, efforts to address smoking, or some combination of these factors. Further, we used the Socio-
demographic Index (SDI), a new summary measure of overall development from GBD 2015, to examine 
levels and trends in smoking prevalence and attributable burden across the development spectrum. 
 
Implications of all the available evidence 
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Amid gains in tobacco control worldwide, smoking remains a leading risk factor for early death and 
disability. While there have been some success stories, for many countries and territories, faster 
annualised rates of decline in smoking prevalence occurred from 1990 to 2005 compared to 2005 to 
2015. Although smoking prevalence and risk-deleted DALY rates fell across SDI quintiles, population 
growth and aging ultimately offset these gains and contributed to overall increases in smoking-
attributable disease burden in low to middle SDI geographies. Intensified tobacco control and 
strengthened monitoring are required to further reduce smoking prevalence and attributable burden, 
particularly given that such demographic factors like population ageing are not easily amenable to 
intervention.  
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Introduction 
The toll of tobacco on population health is immense. Smoking remained the second-leading risk factor 
for early death and disability globally in 2015. Smoking has claimed more than five million lives each 
year since 1990,1 and its contribution to overall disease burden is growing, especially among lower 
income countries. The negative effects of smoking extend well beyond individual and population 
health,2 as billions of dollars in lost productivity and healthcare expenditure are related to smoking 
every year.3 Successfully combatting the tobacco industry’s pursuit of new smokers has been further 
complicated by the substantive – and sometimes rapid  – social, demographic, and economic shifts 
occurring worldwide.4–6 As the tobacco industry moves to target previously untapped markets, including 
women, youth, and people living in low- and middle-income countries,6,7 strong tobacco control policies 
and timely monitoring of smoking patterns is imperative. 
 
The last decade has brought a significant expansion and strengthening of tobacco control initiatives, 
harnessing a wide range of effective interventions and policy instruments for addressing the tobacco 
epidemic. Successful strategies include taxation of tobacco products,9 bans on smoking in public places 
and instituting smoke-free zones,10,11 restrictions on the marketing and promotion of cigarettes, 
including plain packaging laws,12 community- and nation-wide smoking cessation interventions,13,14 and 
enforcement of both text and pictorial warning labels on tobacco products.15,16  Efforts to implement 
comprehensive tobacco control policies culminated in the adoption of the World Health Organization’s 
(WHO) Framework Convention on Tobacco Control (FCTC) in 2003.17 The FCTC, the world’s first public 
health treaty, is viewed as a key driver of recent progress in reducing tobacco consumption and smoking 
prevalence in many regions of the world.18 As of 2016, 180 parties have ratified the FCTC,19 and many 
use WHO’s MPOWER measures,20 established in 2008, to guide national and local FCTC compliance.21 
More recently, WHO introduced the 25x25 Non-communicable Disease (NCD) targets, which include 
decreasing tobacco use by 30% between 2010 and 2025.22 A number of countries have committed to 
even stronger anti-smoking goal, setting national targets to become tobacco-free.23 Additionally, 
strengthening FCTC implementation was explicitly included in the United Nations’ Sustainable 
Development Goals (SDGs), using age-standardised smoking prevalence as an indicator to track 
progress.24 With tobacco control’s increasing prioritisation on the global stage, accurately monitoring 
patterns in smoking and associated health outcomes is critical for identifying optimal intervention 
strategies across geographies, demographic groups, and the development spectrum. 
 
Previous analyses of smoking prevalence and attributable disease burden often were hindered by poor 
data availability, methodological limitations, or both.25–27 Investments in survey series focused on 
tobacco, such as the Global Adult Tobacco Surveys (GATS) and the Global Youth Tobacco Surveys (GYTS), 
have supported more in-depth assessments of national tobacco use.28 Nonetheless, remaining data gaps 
across countries and time, as well as differences in smoking-related questions and definitions among 
available data sources, necessitated considerable analytic improvements to produce a systematic and 
consistent understanding of smoking patterns. As part of the Global Burden of Diseases, Injuries, and 
Risk Factors study for 2013 (GBD 2013), Ng and colleagues generated the first comprehensive, 
comparable estimates of smoking prevalence and tobacco consumption for 188 countries from 1980 to 
5 
 
201329 Since then, other studies have used similar data synthesis approaches to project smoking trends 
from 2010 to 2025 in 173 countries for men and 178 countries for women.30 Previous GBD studies31,32 
have evaluated the contribution of smoking to overall disease burden through the comparative risk 
assessment (CRA) framework developed by Murray and Lopez.33 Recent studies have quantified the 
global effects of tobacco on achieving NCD mortality targets34 and life expectancy,35 while several 
examined smoking-attributable mortality and nonfatal health outcomes for specific locations.36,37 Yet 
few tobacco research endeavours can draw from the same breadth of data sources, analytic rigor in data 
synthesis, and independent, international collaboration as supported by the GBD.  
 
In this analysis, we used the GBD 2015 study to assess smoking prevalence and smoking-attributable 
disease burden, based on deaths and disability-adjusted life-years (DALYs), by sex and age group for 195 
countries and territories from 1990 to 2015. Since GBD 2013, we substantially improved both the 
quantity of data informing our estimation process as well as the modelling strategies used to calculate 
smoking prevalence and attributable burden. For the first time, we investigate differences in smoking 
prevalence and attributable burden alongside indices of overall development, as measured by the Socio-
demographic Index (SDI), a summary measure of income per capita, educational attainment, and total 
fertility rate (TFR).38 Additionally, we assess age and sex patterns by birth cohort across levels of 
development. Finally, we conduct a decomposition analysis of potential drivers of smoking-attributable 
disease burden over time, seeking to parse out changes due to smoking exposure from those due to 
other demographic factors, such as population growth and aging. 
 
 
Methods 
This study follows the overall GBD 2015 CRA framework, details of which have been previously 
published.1 Here we summarise the main steps in the estimation process and provide more detail on 
data inputs and modelling strategies in the appendix pp 5-9. This study fully adheres to the Guidelines 
for Accurate and Transparent Health Estimates Reporting (GATHER).39 
 
Estimating smoking exposure 
We calculated two exposure measures in this study: prevalence of daily smoking of tobacco and the 
smoking impact ratio; detailed descriptions of these methods have been published previously.29 We 
defined a daily smoker as an individual using any type of smoked tobacco product, including both 
manufactured and hand-rolled cigarettes, hookah, cigars, pipes, and bidis, among others, on a daily 
basis. We focused on daily smoking, as opposed to current smoking, because the majority of data 
sources measure it directly and also because there are more significant health effects associated with 
daily smoking.40,41 To estimate daily smoking prevalence we used 2,818 data sources, covering 2,928 
geography-years of data, identified through the Global Health Data Exchange (GHDx), WHO InfoBase 
Database, and International Smoking Statistics Database. At least one data source was available for 191 
out of 195 countries and territories, and 140 locations had at least five data sources. Countries lacking 
data were Central African Republic, Angola, Somalia, and South Sudan; additional details on data 
sources are found in the appendix pp 5-6. For any data that did not match our exposure definition (daily 
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smoking of any tobacco product), we adjusted for frequency of use or type of tobacco consumed to 
avoid potential biases. Improving upon methods used by Ng and colleagues,29 we adjusted for smoking 
frequency and type simultaneously, which allowed us to account for their mutual correlations with each 
other (appendix pp 7-8). Secondhand smoke exposure is estimated separately in GBD and is not included 
in this analysis. 
 
We generated estimates of smoking prevalence by sex and five-year age groups starting at age 10. Any 
data that spanned multiple age groups or were reported for both sexes combined were split based on 
the age-sex patterns observed from data sources with multiple age-sex groupings; this process was 
based on the approach used by Ng and colleagues.29 We then used spatiotemporal Gaussian process 
regression (ST-GPR), a data synthesis method widely used in GBD,1 to model smoking prevalence. ST-
GPR allowed us to draw strength across multiple dimensions (geography, time, and age), incorporate 
both data and model uncertainty, and produce a full time-series of estimates for all 195 geographies in 
this analysis. In brief, the mean function used in GPR was a combination of a hierarchical linear mixed-
effects model using supply-side tobacco availability as a covariate plus residuals smoothed across 
geography, time, and age. Full details on the modeling strategy, including the data sources and 
estimation process used for the supply-side tobacco availability covariate, are provided in the appendix 
pp 5-9. 
 
The second exposure measure, the smoking impact ratio, was first described by Peto and Lopez42 as part 
of a method to estimate smoking-attributable burden in the absence of information on smoking 
patterns. The smoking impact ratio is defined as the population lung cancer mortality rate in excess of 
the background lung cancer mortality rate observed among non-smokers in the population, relative to 
the excess lung cancer mortality rate observed in a reference group of smokers. We computed the 
smoking impact ratio for each analytic unit using the geography-, year-, age-, and sex-specific population 
lung cancer mortality rates from GBD 2015,43 and reference group lung cancer mortality rates from 
prospective cohort studies (appendix p 9). 
 
Defining risk-outcome pairs 
We assessed all available evidence that supported causal relationships between smoking and 38 health 
outcomes using a systematic approach adapted from Hill’s criteria for causation44 and the World Cancer 
Research Fund evidence grading schema (appendix p 9).45 For GBD 2015, we added seven new outcomes 
to those identified in GBD 2013:31 larynx cancer, peptic ulcer disease, rheumatoid arthritis, cataract, 
macular degeneration, hip fracture, and non-hip fracture.  
 
Estimating attributable burden 
We used five-year lagged smoking prevalence in estimating smoking attributable burden for 
cardiovascular diseases, tuberculosis, diabetes, lower respiratory infections, asthma, cataracts, macular 
degeneration, fractures, rheumatoid arthritis, and peptic ulcer disease. We chose a five-year lag based 
on literature showing that most risk-reduction occurs within five years of quitting smoking.46 We used 
the smoking impact ratio in estimating smoking attributable burden for cancers, chronic obstructive 
pulmonary disease (COPD), interstitial lung disease, other chronic respiratory diseases, and 
7 
 
pneumoconiosis. A complete list of outcomes and their associated exposure metric is available in the 
appendix pp 31-32. 
 
For each outcome included in this analysis we used relative risk (RR) estimates derived from prospective 
cohort studies comparing smokers to never smokers (appendix p 9). Population attributable fractions 
(PAFs) were calculated based on estimates of exposure, RRs, and the theoretical minimum risk exposure 
level (TMREL) for smoking (zero smoking). Following PAF calculation, we multiplied estimates of deaths 
and DALYs by outcome-specific PAFs, and then summed them across all 38 outcomes to compute overall 
disease burden attributable to smoking. The appendix provides more detail on the process for 
computing smoking attributable burden (p 9).  
 
Uncertainty analysis 
We captured and propagated uncertainty through all steps of the analysis, including sampling 
uncertainty from data extraction, uncertainty from models used to adjust data reported in non-standard 
frequency-type combinations, uncertainty in the ST-GPR model, and uncertainty in deaths and DALYs for 
the 38 included outcomes. Ultimately, we produced 1,000 draws of exposure and attributable burden 
estimates, for each geography, year, age, and sex, from which 95% uncertainty intervals (UIs) were 
taken using the 2.5 percentile and 97.5 percentile of the distribution. 
   
Decomposing changes in deaths and DALYs  
To parse out the drivers of changes in smoking attributable DALYs from 2005 to 2015, we assessed the 
relative contribution of four factors: (1) population growth, (2) population age structure, (3) risk-deleted 
DALY rates, and 4) smoking exposure. Risk-deleted rates are defined as the DALY rates that would have 
been observed if we removed smoking as a risk factor. We estimated risk-deleted DALY rates by 
multiplying the observed cause-specific DALY rates by one minus the cause-specific PAFs. For the 
decomposition analysis, we used the methods developed by Das Gupta;47 see the appendix p 10 for 
more detail. 
 
Smoking and its relationship to SDI 
We present results aggregated by level of SDI, a composite indicator of development estimated for each 
geography based on lag-distributed income per capita, average educational attainment among 
individuals over age 15 years, and TFR in 2015. SDI values were scaled to a range from 0 to 1, with 0 
representing the lowest educational attainment, lowest income, and highest TFR observed in any 
geography between 1980 and 2015, and 1 equaling the highest educational attainment, highest income, 
and lowest TFR during this time. Further details on SDI computation are available elsewhere, 43 and SDI 
values for each geography are included in the appendix pp 21-25. 
 
Role of the funding source 
The funders of the study had no role in study design, data collection, data analysis, data interpretation, 
or writing of the report. The corresponding author had full access to all the data in the study and had 
final responsibility for the decision to submit for publication. 
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Results  
Global, regional, and national levels and trends of daily smoking 
Globally, the age-standardised prevalence of daily smoking was 25.0% (95% uncertainty interval 24.2–
25.7%) in men and 5.4% (5.1–5.7%) in women, in 2015 (Table 1). Fifty-one countries and territories had 
significantly higher prevalence of smoking than the global average for men, and these countries were 
primarily located in Central and Eastern Europe and Southeast Asia (Figure 1). For women, 70 countries, 
mainly in Western and Central Europe, significantly exceeded the global average. Among men, 
prevalence of daily smoking was highest in middle SDI countries, whereas for women high SDI countries 
had the highest prevalence of daily smokers (Figure 2). Compared to other SDI levels, low SDI 
geographies generally had the lowest prevalence of daily smoking for both sexes. In 2015, Kiribati 
(47.8% [43.8–51.5%]), Indonesia (46.7% [43.9–49.5%]), and Laos (46.5% [42.6–50.3%]) recorded the 
highest levels of smoking among men, while Greenland (44.3% [41.1–47.6%]), Bulgaria (28.3% [24.5–
32.0%]), and Greece (27.2% [24.6–29.6%]) registered the highest levels of smoking among women.  
 
Between 1990 to 2015, the global age-standardised prevalence of daily smoking fell significantly for 
each sex, decreasing by 28.4% (25.8-31.1%) for men and 34.4% (29.4-38.5%) for women (Table 1). 
Fourteen countries (Algeria, Australia, Brazil, China, Democratic Republic of the Congo, Dominica, 
Iceland, Kenya, the Netherlands, New Zealand, Norway, Sweden, Switzerland, and the USA), eight of 
which are high SDI countries, recorded statistically significant annualised rates of decline 1990-2005 and 
2005-2015, indicating sustained progress in tobacco control. Eighteen countries showed a faster 
annualised rate of reduction in daily smoking in the most recent decade compared to 1990-2005. The 
annualised rate of change for men increased significantly in six countries (Chile, Cyprus, Guyana, 
Romania, Saudi Arabia, and Serbia) between 1990 and 2005, but only one country (Congo) from 2005 to 
2015. For women, the annualised rate of change increased significantly for six countries (Chile, Greece, 
Indonesia, Japan, Portugal, and South Korea) between 1990 and 2005 compared to one country (Kuwait) 
from 2005 and 2015. Focusing on the most recent decade, since 2005, 27.2% (n=53) of countries and 
territories recorded statistically significant decreases in age-standardised prevalence of male daily 
smoking, whereas only 16.4% (n=32) saw statistically significant reductions for women.  
 
A focus on countries with large smoking populations 
In 2015, there were 933.1 million (831.3–1,054.3 million) daily smokers in the world, 82.3% of whom 
were men (768.1 million [690.1–852.2 million]). The ten countries with the largest number of smokers 
together accounted for 63.6% of the world’s daily smokers. China, India, and Indonesia – the three 
leading countries in total number of male smokers – accounted for 51.4% of the world’s male smokers in 
2015. On the other hand, USA, China, and India, which were the leading three countries in total number 
of female smokers, only accounted for only 27.3% of the world’s female smokers. Together, these 
results suggest that the tobacco epidemic is less geographically concentrated for women than for men. 
In 2015, 33.1% of male smokers and 8.7% of female smokers lived in China alone, amounting to 253.9 
million (241.2–266.6 million) and 14.4 million (10.5–19.5 million) daily smokers, respectively (Table 2). 
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Among the ten countries with the largest number of total smokers in 2015, seven recorded statistically 
significant declines in male smoking prevalence and five experienced statistically significant declines in 
female smoking prevalence since 1990. Of these countries, Brazil recorded the largest overall reduction 
in prevalence for both male and female daily smoking, which dropped by 56.5% (51.9–61.1%) and 55.8% 
(48.7–61.9%), respectively, between 1990 and 2015. Indonesia, Bangladesh, and the Philippines did not 
experience significant declines in male prevalence of daily smoking since 1990, and the Philippines, 
Germany, and India had no significant declines in smoking among women. Each of the three countries 
with female age-standardised smoking prevalence less than 3.0% (China, India, and Bangladesh) 
succeeded in keeping smoking prevalence low among women. Notably, female prevalence of daily 
smoking significantly increased in Russia and Indonesia since 1990 (Table 2). 
 
A focus on adolescents  
Delving into the smoking patterns of adolescents can shed light on trends in smoking initiation. Most 
initiation of sustained smoking occurs between ages 15 and 19,48 so in this section we are focusing on 
populations aged 15 to 19 years. Between 1990 and 2015, the global prevalence of daily smoking for this 
age group significantly decreased for each sex, falling from 16.1% (14.4–18.0%) to 10.6% (9.3–12.1%) for 
men and from 4.8% (4.3–5.6%) to 3.0% (2.6–3.7%) for women (Table 2). Despite global decreases, 
several countries still had a high prevalence of smoking among individuals aged 15-19 years. In 2015, 
there were 22 countries with female smoking prevalence in this age group above 15.0%, 18 of which 
were located in Western or Central Europe. Countries with high male smoking prevalence were much 
more dispersed. Of the 26 countries with male smoking prevalence above 20.0%, seven were in Eastern 
Europe, and the remainder were spread across 10 other regions (Supplemental Figure S2). The rank of 
countries with the largest smoking populations for the 15-19 age group was, for the most part, 
consistent with the rank for all-age smoking populations (Table 2). Among countries with the largest 
smoking populations, Germany had the highest smoking prevalence among young women (15.9%, 
[10.1–23.4%]), which did not significantly change between 1990 and 2015. Indonesia not only had one 
of the highest prevalence of daily smoking among men aged 15-19 years (27.7%, [18.4–38.3%]), but also 
the third largest smoking population in this age group and experienced no significant change in smoking 
prevalence among young adults between 1990 and 2015. 
 
While no country exhibited a significant increase for men or women in this age group since 2005, only 
three countries saw smoking prevalence among 15-to-19 year-olds significantly drop for both men and 
women since 2005 (New Zealand, Iceland, and the USA). Iceland had the largest significant decline 
among men, decreasing from 14.8 (11.7–18.5%) in 2005 to 9.0 (5.6–13.3%) in 2015. New Zealand had 
the largest significant decline among women, dropping from 20.8 (18.1–23.8%) in 2005 to 12.5% (10.1–
15.5%) in 2015. 
 
Shifts in patterns of smoking across cohorts 
Parsing out daily smoking prevalence by age group and birth cohort allows for a more fine-grained 
examination of smoking prevalence, age patterns, and temporal trends by level of development (Figure 
2). Male age patterns of smoking were fairly consistent across levels of SDI, with prevalence generally 
peaking between the ages of 25 and 35 years. For women, however, age patterns varied more by SDI: 
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female smoking prevalence typically peaked around age 25 for high and high-middle SDI countries, while 
prevalence generally increased until the age of 60 in low to middle SDI countries. Across birth cohorts, 
smoking prevalence decreased by age group, sex, and SDI level. The most notable declines were 
observed in high and high-middle SDI countries for men, where sizeable reductions in smoking 
prevalence among 15 to 24 year-olds occurred across birth cohorts. Middle SDI countries, which have 
the highest levels of daily smoking among men, experienced minimal changes in prevalence across birth 
cohorts, suggesting far less progress in curbing smoking initiation or promoting cessation. For women, 
prevalence is consistently lower compared to men; nevertheless, reductions in smoking prevalence 
across birth cohorts generally were smaller than those observed for men. For both men and women, 
Latin America had notable success in reducing initiation and promoting earlier cessation, as evidenced 
by their marked reductions in prevalence in the 15-19 and 20-24 age groups along with an earlier age of 
peak prevalence and faster decline from peak prevalence in more recent birth cohorts (Supplemental 
Figure S4 in the appendix pp 17-18). 
 
Deaths and disease burden attributable to smoking 
In 2015, 6.4 million deaths (5.7–7.0 million) were attributable to smoking worldwide, representing a 
4.7% (1.2-8.5%) increase in smoking-attributable deaths since 2005. Over 75% of these deaths were 
among men, and 52.2% took place in four countries (China, India, USA, and Russia) (Table 3). Smoking 
was the second-leading risk factor for attributable mortality among both sexes in both 2005 and 2015, 
following high-systolic blood pressure, which was the leading risk factor globally.1 On the other hand, 
the relative ranking of smoking-attributable disease burden, as measured in DALYs, increased from third 
to second between 2005 and 2015. In 2015, there were 148.6 million (134.2–163.1 million) smoking-
attributable DALYs globally, and smoking was the leading risk factor for attributable disease burden in 24 
countries, an increase from 16 countries in 1990 (Figure 3). Further, smoking was ranked among the 
leading five risk factors for 109 countries in 2015. Between 2005 and 2015, only Egypt recorded a 
significant increase in the age-standardised smoking-attributable mortality rate among both sexes, 
increasing by 11.4% (0.3–24.7%) over that time period. On the other hand, 82 countries saw significant 
declines in their age-standardised smoking-attributable mortality rates since 2005. 
 
Overall, in 2015, cardiovascular diseases (41.2%), cancers (27.6%), and chronic respiratory diseases 
(20.5%) were the three leading causes of smoking-attributable age-standardised DALYs for both sexes. 
Considering all risk factors, smoking was the leading risk factor for neoplasms and chronic respiratory 
diseases, but only the ninth leading risk factor for cardiovascular diseases.1 The 30 leading causes of 
DALYs attributable to smoking, including changes over time, are shown in the appendix pp 19-20.  For 
women, the leading cause of smoking-attributable DALYs was COPD, whereas the leading cause for men 
was ischaemic heart disease.  
 
Decomposing changes in attributable burden due to smoking 
Relative to changes in smoking exposure, the main drivers of overall changes in attributable burden due 
to smoking varied by both sex and SDI level (Figure 4). Since 2005, all-cause DALYs attributable to 
smoking for men decreased by 11.8% (10.0–13.9%) in high-SDI countries, the only SDI level with a 
significant decrease in attributable burden for men. For women, only middle-SDI countries experienced 
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a significant reduction in all-cause DALYs attributable to smoking (a 22.6% decline [9.0–32.8%]) between 
2005 and 2015. In both instances, a combination of declining smoking exposure and declining risk-
deleted DALY rates contributed to overall reductions. Conversely, all-cause burden due to smoking 
significantly increased among low SDI and low-middle SDI countries since 2005 for men. This rise in 
attributable DALYs was primarily driven by a combination of population growth and population aging for 
both sexes. Among women, while rising exposure to smoking has resulted in increased DALYs due to 
smoking for low-middle SDI countries, this increase was not statistically significant. In general, 
population growth was the leading factor for increasing attributable burden due to smoking among the 
low SDI countries between 2005 and 2015. For countries of middle to high SDI, more pronounced sex 
differences emerged. For instance, declines in male smoking prevalence propelled an overall reduction 
in attributable burden for high SDI countries, whereas changes in smoking exposure had minimal effects 
on overall burden for women at similarly high levels of SDI. 
 
A complete dataset of all results by geography, year, sex, and age group can be downloaded through the 
GHDx (http://ghdx.healthdata.org/), and an interactive data visualization of smoking prevalence results 
is available at http://vizhub.healthdata.org/tobacco/.  
  
Discussion  
Despite over half a century of unequivocal evidence of the harmful effects of tobacco on health,49,50 in 
2015, one out of every four men in the world was a daily smoker. Prevalence has been, and remains, 
significantly lower among women – approximately one in every 20 women smoked daily in 2015. 
Nonetheless, considerable progress has been accomplished over the past 25 years. Specifically, the age-
standardised global prevalence of daily smoking fell to 15.3% (14.8-15.9%), a 29.4% (27.1-31.8%) 
reduction from 1990, with smoking rates declining from 34.9% (34.1-35.7%) to 25.0% (24.2-25.7%) 
among men and from 8.2% (7.9-8.6%) to 5.4% (5.1-5.7%) among women. These reductions were 
particularly pronounced in high SDI countries and Latin America, likely reflecting concerted efforts to 
implement strong tobacco control policies and programs in Brazil and Panama, among others. 
 
Yet amid these gains, many countries with persistently high levels of daily smoking recorded marginal 
progress since 2005, and smoking remained among the leading risk factors for early death and disability 
in more than 100 countries in 2015, accounting for 11.6% of global deaths (10.4–12.8%) and 6.3% (5.6–
7.1%) of global DALYs. Smoking patterns diverged by geography, level of development, sex, and birth 
cohort, emphasising the need for tailored approaches to change smoking behaviours. Although male 
smoking prevalence still far exceeded that of female smokers in 2015, the most pronounced reductions 
in smoking prevalence since 1990 were generally found for men – and more places saw minimal changes 
or increases in smoking among women. These trends highlight how the tobacco epidemic – and 
corresponding industry forces – has expanded beyond a male-centred health challenge. 
 
Low to middle SDI countries saw increased disease burden attributable to smoking since 2005, a trend 
that that occurred despite variable declines smoking prevalence and risk-deleted DALY rates. Population 
growth or ageing – or a combination of both – ultimately contributed to increased disease burden 
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attributable to smoking among these countries. In higher SDI countries, population growth and ageing 
offset the potential for larger gains in places where notable declines in smoking prevalence and risk-
deleted DALY rates occurred. This finding points to a critical challenge ahead for tobacco control: unless 
progress in reducing current smoking and preventing initiation can be substantially accelerated, 
demographic forces – which are far less amenable to immediate intervention – are poised to heighten 
the disease burden associated with smoking’s global toll. 
 
Since 2005, the year when the FCTC was enforced, it has redefined global, regional, and national 
approaches to tobacco control and policy.51,52 Case studies point to the successful uptake and 
enforcement of FCTC components in many countries with particularly prominent reductions in smoking 
prevalence. Pakistan, Panama, and India stand out as three countries that have implemented a large 
number of tobacco control policies over the past decade and have experienced remarkable declines in 
the prevalence of daily smoking since 2005, compared to declines observed between 1990 and 2005.53–
55 At the same time, many countries, including Australia, Brazil, Canada, South Korea, and USA, among 
others, achieved sizeable declines in smoking prevalence well before FCTC adoption.56–61 Altogether, 25 
countries recorded a faster annualised rate of decline from 1990 to 2005 than from 2005 to 2015. 
 
Brazil which has achieved the third largest significant decline in age-standardised smoking prevalence 
since 1990, is one success story that can be referred to by other countries wishing to make significant 
gains in tobacco control. Brazil accomplished this reduction through a combination of tobacco control 
policies that began with advertising restrictions and smoking bans in some public places starting in 1996 
and culminated with Brazil achieving the highest level of achievement in all MPOWER measures except 
for monitoring by 2011. Policies included strict warning label requirements, comprehensive public 
smoking bans, and a ban on all forms of direct and indirect advertisement. Additionally, Brazil promoted 
cessation programs, including national smoking quit lines and cost-covered nicotine replacement 
therapy and cessation counseling by physicians, while running regular anti-smoking mass-media 
campaigns. Also, Brazil complemented policies with fiscal interventions that included raising taxes and 
establishing minimum prices for tobacco products. Finally, Brazil has achieved high-levels of compliance 
with policies through enforcement.62–66   
 
Critics of the FCTC argue that the treaty’s effectiveness may be limited in various settings, especially 
since compliance has lagged in many countries of low-to-middle SDI.67–69 A complex interplay of factors 
are involved in tobacco control, ranging from the differences in intensity of FCTC implementation and 
enforcement at local levels to shifts in sociocultural norms regarding smoking, particularly among 
women. For instance, marketing campaigns have long sought to reframe the female smoker as strong, 
independent, and socially desirable.8,70 The FCTC, while necessary and vital for creating the policy 
environment for more effective tobacco control worldwide, is not sufficient to fully address each 
country’s tobacco control needs. Rather, countries will need to both implement FCTC-stipulated 
measures and supplement such policies and programs with strong enforcement and high rates of 
compliance. For example, India, where 11.2% of the world’s smokers live, supplemented the Cigarettes 
and Other Tobacco Products Act (COTPA) with the creation of a National Tobacco Control Programme 
(NTCP) in 2007. NTCP was created to strengthen implementation and enforcement of the various 
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provisions of COTPA at the state and district level. It has been rolled out in phases and currently covers 
about 40% of all districts in India.71 
 
Despite concerted efforts to control tobacco around the world, there remain a number of countries 
where current levels and recent trends raise concern about the potential impact of the tobacco 
epidemic on their population. For example, Indonesia, a country with very high levels of smoking, 
particularly among men and where 56.4% of men aged 20-24 years are daily smokers, has not yet 
ratified the FCTC and scores very poorly on the MPOWER indicators.18 Also, in Russia prevalence among 
women has been increasing, and, until recently, there were very few laws related to tobacco control.72 
Russia passed a comprehensive tobacco control policy in 2014, and alongside effective implementation 
has the potential to achieve progress on tobacco control.73 As a region, Eastern Europe has seen a 
statistically significant increase in smoking prevalence among women since 1990. Increases among 
women, along with a sustained high prevalence of male smokers, can be linked to tobacco industry 
targeting during the 1990s.6 The tobacco industry is now turning its focus toward emerging markets in 
sub-Saharan Africa, seeking to exploit the continent’s patchwork tobacco control regulations and limited 
resources to combat industry marketing advances.74,75 Given the large effects of population growth and 
aging on smoking-attributable disease burden – and Africa’s rapidly changing demographic profile – a 
renewed dedication to strong, proactive tobacco policies and monitoring will be vital for the continent.76 
 
Understanding what works – and what does not – for tobacco control across contexts and within 
subpopulations (i.e., men and women, younger and older individuals, various socioeconomic groups) is 
of growing priority to donors, governments, and development partners alike. WHO assesses country 
achievements of MPOWER measures and publishes updated findings every two years.18 Extending this 
important work of tracking tobacco control policy status and effectiveness in a more disaggregated, 
routine manner is a critical need, as evidenced by our study’s heterogeneous trends in smoking 
prevalence by level of SDI, sex, and even birth cohort. For instance, little evidence and consensus exist 
on whether tobacco control policies and programs have differential effects for men and women, across 
levels of socioeconomic status,77 or in different cultures.78  
 
The 2030 agenda features tobacco control as a key component to sustainable development, with SDG 
Target 3.a calling for stronger FCTC implementation.24 In many ways, the inclusion of tobacco control for 
the SDGs is a success, as the Millennium Development Goals (MDGs) were mainly focused on maternal 
and child health outcomes, specific areas of poverty reduction, and a subset of risk factors.79 Reducing 
the prevalence of smoking (Indicator 3.a.1) may be an important avenue for country-level progress on 
the health-related SDGs, particularly given the strong linkages between smoking and NCD mortality 
(Indicator 3.4.1). In fact, several countries with the largest gains on the health-related SDG index 
between 2000 and 2015 recorded particularly sizeable reductions in age-standardised prevalence of 
smoking (e.g., Colombia and Iceland).80 Nonetheless, the utility and potential impact of the SDGs on 
tobacco control may be hindered by the vagueness of Target 3.a (“Strengthen the implementation of 
the WHO FCTC in all countries, as appropriate”) and absence of defined targets for reducing smoking 
prevalence by 2030. The 25x25 targets set by the WHO NCD Global Monitoring Framework,22 while 
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criticised for not being ambitious enough,81 lay the foundation for more specific policy pursuits and 
greater accountability. 
 
Ultimately, to move all countries toward stronger tobacco control by 2030, global agenda-setting 
exercises must be accompanied by improvements in the routine monitoring of smoking behavior, 
alongside improvements in policy formulation, enforcement, and compliance. Without valid and reliable 
data, these efforts risk being more aspirational than grounded in evidence-informed action. The advent 
of GATS, GYTS, and other multi-country survey series with tobacco modules substantially improved data 
availability on smoking prevalence, yet the disadvantages associated with such surveys – high cost, time 
lags between data collection, inconsistent questions across survey series, sample restrictions for young 
populations, and a reliance on self-reported smoking behavior – necessitate the development of robust, 
locally focused, timely, objective, and low-cost methods of tracking smoking trends. Development of 
low-cost routine monitoring systems is critical for tobacco control in low and low-middle SDI countries 
and territories, where the average time between surveys containing tobacco indicators was over 3 
years, compared to less than one year in high SDI countries and territories. Supplementing surveys with 
biomarker collection for objective measurement of smoking status is essential because self-reported 
smoking prevalence is believed to be severely underestimating true smoking prevalence,82–85 especially 
in population subgroups or places where tobacco use may not be culturally acceptable. Standardising 
tobacco use indicators will improve comparability of estimates across time and space, and will avoid 
increased uncertainty in estimates resulting from the need to adjust indicators to match a gold standard. 
 
Limitations 
Our findings should be interpreted taking into consideration the study’s limitations. First, our exposure 
estimation focused on smoked tobacco, and did not include smokeless tobacco products and e-
cigarettes; the inclusion of these tobacco products will occur in upcoming iterations of the GBD. Second, 
our definition of smoking exposure pertained to current daily smokers, and did not include occasional or 
former smokers, which may underestimate the attributable disease burden to smoking, especially 
among populations who tend to be less likely to smoke daily, such as women, children and young adults, 
and individuals with less disposable income. Third, we did not account for the intensity or duration of 
smoking, another limitation that will be addressed in future rounds of the GBD. Fourth, we potentially 
introduced additional uncertainty when adjusting for alternative frequency-type definitions and by 
splitting aggregated data into more granular sex-specific age groups. Fifth, the study relied on self-
reported data, and it is possible that reporting biases varied across countries and over time. Sixth, for 
long-term effects of smoking on cancers and chronic respiratory diseases, we used the smoking impact 
ratio method which estimates the lifetime cumulative effect of cigarette smoking using the proxy of 
observed lung cancer versus lung cancer in smokers and non-smokers. This method provides robust 
estimates of the burden of cancers related to tobacco but is not fully consistent with the GBD approach 
of estimating exposure independently of the outcomes affected by exposure. Also, the smoking impact 
ratio method is based on the cumulative effect of cigarette smoking rather than all types of tobacco 
smoking, and may be less robust for geographies where non-smoker lung cancer may be significantly 
affected by household air pollution, ambient air pollution, or other factors. With increased data on 
smoking behaviors, including duration and intensity of use, direct estimation of attributable burden will 
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be incorporated in future iterations of the GBD. Seventh, our burden estimates are likely underestimates 
because relative risk values used for estimating PAFs may not fully represent all possible risk-outcome 
pairs experienced by sex, age group, and over time.86 We substantially expanded our database for 
smoking risk-outcome pairs for GBD 2015, and plan to continue such efforts in future GBD analyses. 
Additionally, we did not include the effects of maternal smoking on adverse birth outcomes. Also, 
burden estimates did not account for the effect of both indoor and outdoor air pollution potentiating 
risks. Finally, minimal risk-outcome data were available for populations younger than 30 years, and 
therefore burden attribution was limited to age groups 30 and older. As more data become available for 
health outcomes associated with smoking at younger ages, such attribution will occur within GBD.  
 
Conclusion 
Despite over fifty years of anti-tobacco efforts, smoking remains a leading global risk factor. Its toll will 
remain substantial without more concerted policy initiatives, policy compliance and enforcement, and 
sustained political will to offset commercial interests. Despite progress in some settings, the war against 
tobacco is far from won, particularly in the countries with the highest numbers of smokers. The 
staggering toll of smoking on health echoes well beyond the individual, especially as tobacco threatens 
to exact long-term financial and operational burdens on already resource-constrained health systems. In 
order to significantly and permanently bend the global tobacco epidemic’s trajectory, a renewed and 
sustained focus is needed on comprehensive tobacco control policies around the world. Success is 
possible, but requires effective and aggressively enforced policies and laws. Intensified efforts are also 
greatly needed to keep smoking prevalence rates low in populations which have not experienced a 
devastating epidemic yet, and to prevent children, adolescents, and young adults from starting to 
smoke.  
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Figures and tables 
Figure 1. Age-standardised prevalence of daily smoking for men (A) and women (B), in 2015. 
ATG=Antigua and Barbuda; VCT= Saint Vincent and the Grenadines; BRB=Barbados; COM=Comoros; 
DMA=Dominica; GRD=Grenada; MDV=Maldives; MUS=Mauritius; LCA=Saint Lucia; TTO=Trinidad and 
Tobago; TLS=Timor-Leste; SYC=Seychelles; W Africa=Western Africa; E Med.=Eastern Mediterranean; 
MLT=Malta; SGP=Singapore; MHL=Marshall Islands; KIR=Kiribati; SLB=Solomon Islands; FSM=Federated 
States of Micronesia; VUT=Vanuatu; WSM=Samoa; FJI=Fiji; TON=Tonga. 
Figure 2. Prevalence of daily smoking across birth cohorts over time, at the global level and by SDI 
quintile, for men (A) and women (B). Birth cohorts are colour-coded by five-year intervals, with the 
most recent birth cohort in red (2005) to the least recent birth cohort in dark blue (1910). Each dot 
represents the prevalence of daily smoking for a given birth cohort and age group. SDI = Socio-
demographic Index. 
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Figure 3. Rankings of smoking as a risk factor for all-cause, all-age attributable DALYs for both sexes 
combined in 1990 (A), 2005 (B), and 2015 (C). DALYs = disability-adjusted life-years. ATG=Antigua and 
Barbuda; VCT= Saint Vincent and the Grenadines; BRB=Barbados; COM=Comoros; DMA=Dominica; 
GRD=Grenada; MDV=Maldives; MUS=Mauritius; LCA=Saint Lucia; TTO=Trinidad and Tobago; TLS=Timor-
Leste; SYC=Seychelles; W Africa=Western Africa; E Med.=Eastern Mediterranean; MLT=Malta; 
SGP=Singapore; MHL=Marshall Islands; KIR=Kiribati; SLB=Solomon Islands; FSM=Federated States of 
Micronesia; VUT=Vanuatu; WSM=Samoa; FJI=Fiji; TON=Tonga.  
Figure 4 Decomposition of changes in all-cause DALYs attributable to smoking from 2005 to 2015, by 
SDI, for men (A) and women (B). SDI quintiles are reported in order of the number of total all-cause, all-
age DALYs attributable to smoking in 2015. Changes due to population growth, population aging, risk 
exposure (smoking prevalence), and the risk-deleted DALY rate are shown. Locations are reported in 
order of the number of attributable DALYs for both sexes in 2015. DALYs = disability-adjusted life-years. 
SDI = Socio-demographic Index. 
 
Table 1. Age-standardised prevalence of daily smoking in 2015 and percent change in age-
standardised prevalence from 1990-2015, 1990-2005, and 2005-2015 for men and women. For percent 
change estimates, red indicates an increase in prevalence, blue indicates a decrease in prevalence, and 
bold indicates a statistically significant change. 95% uncertainty intervals are reported in parentheses: 
(lower, upper).    
 
Table 2. Size of the smoking population, prevalence, and 1990-2015 percent change in prevalence, by 
sex, for the ten countries with the largest smoking populations and globally. Age-standardised 
estimates and estimates for the 15-19 age group are reported. Overall rank is calculated based on the 
size of the smoking population, both sexes and all ages (10+) combined. Ages 15-19 rank is calculated 
based on the size of the smoking population aged 15-19, both sexes combined. For percent change 
estimates, red indicates an increase in prevalence, blue indicates a decrease in prevalence, and bold 
indicates a statistically significant change. 95% uncertainty intervals are reported in parentheses: (lower, 
upper). 
 
Table 3. All-cause all-age (30+) deaths and DALYs and all-cause age-standardized mortality and DALY 
rates (per 100) in 2015 for men and women. 95% uncertainty intervals are reported in parentheses: 
(lower, upper).    
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